Cox-2 inhibitors and cardiovascular risk: the data are inconclusive, and these drugs are needed.

Lipani, J

Lipani, J.

Affiliation

Lipani J; Histatek Inc, Fountain Hills, AZ, USA.

Cleve Clin J Med ; 68(11): 961-2, 2001 Nov.

Article in En | MEDLINE | ID: mdl-11718437

Subject(s)

Cyclooxygenase Inhibitors/therapeutic use; Isoenzymes/antagonists & inhibitors; Myocardial Infarction/chemically induced; Research Design; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Contraindications; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors/adverse effects; Drug Therapy, Combination; Humans; Membrane Proteins; Myocardial Infarction/epidemiology; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Risk

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Cyclooxygenase Inhibitors / Isoenzymes / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cleve Clin J Med Journal subject: MEDICINA Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links